Current and emerging therapeutic approaches to hepatitis C infection.
Hepatitis C virus is a frequent disease infecting an estimated 3% of the worlds population. It represents a major health problem and must be combated by all means. The aim of this review is to discuss the current treatment methods, including interferon-alpha, either standard or pegylated, and ribavirin. Emerging treatments will also be discussed for this potentially curable disease.
INSERM Unit 271, Lyon, France.
David
D
Durantel
Vanessa
V
Escuret
Fabien
F
Zoulim
D000818:Animals; D005838:Genotype; D006526:Hepatitis C / Q000188:drug therapy* / Q000235:genetics / Q000276:immunology; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D012254:Ribavirin / Q000627:therapeutic use*
D016898:Interferon-alpha; D012254:Ribavirin